Dr Wendy Wood

Biography

Wendy has over 20 years’ experience in clinical trials and has been a co-applicant on 3 NIHR HTA-funded trials with involvement from design to dissemination. Originally training as a nurse at St George’s Hospital and Great Ormond Street she then worked at the Royal Alexandra Children’s Hospital before going on to study biochemistry BSc and DPhil at University of Sussex. She has worked in Clinical Trials Units at UCL, Southampton and Surrey Universities and for NIHR Research Design Service as a Research Adviser before becoming Director of Brighton & Sussex Clinical Trials Unit in May 2023.

Selected publications

Bertini L, Bogen-Johnston L, Sadhwani S, Middleton J, Sharp R, Wood W, Roland D, Forder J, Cassell J Care Workers and Managers’ Experiences of Implementing Infection Control Guidance in an Epidemic Context: A Qualitative Study in the South East of England, during the COVID-19 Prevaccination Era Health & Social Care in the Community Apr 2023

Hall NJ, Sherratt FC, Eaton S, Reading I, Walker E, Chorozoglou M, et al. Conservative treatment for uncomplicated appendicitis in children: the CONTRACT feasibility study, including feasibility RCT. Health Technol Assess 2021;25(10)

Santer M, Ridd MJ, Francis NA, Stuart B, Rumsby K, Chorozoglou M, Becque T, Roberts A, Liddiard L, Nollett C, Hooper J, Prude M, Wood W, Thomas KS, Thomas-Jones E, Williams HC, Little P. Emollient bath additives for the treatment of childhood eczema (BATHE): multicentre pragmatic parallel group randomised controlled trial of clinical and cost effectiveness. BMJ. 2018 May 3;361

Duley L, Gillman A, Duggan M, Belson S, Knox J, McDonald A, Rawcliffe C, Simon J, Sprosen T, Watson J, Wood W. What are the main inefficiencies in trial conduct: a survey of UKCRC registered clinical trials units in the UK. Trials. 2018 Jan 8;19(1):15.

Williams CL, Weller S, Roberts L, Reading I, Cook A, Little L, Wood W, Stanton L, Roposch A, Clarke NM. Timing of surgical Intervention for developmental dysplasia of the hip: a randomised controlled trial (Hip ‘Op): a randomised controlled trial (Hip ‘Op) Health Technol Assess. 2017 Oct;21(63):1-84

Ottensmeier C, Bowers M, Hamid D, Maishman T, Regan S, Wood W, Cazaly A, Stanton L. Wilms’ tumour antigen 1 Immunity via DNA fusion gene vaccination in haematological malignancies by intramuscular injection followed by intramuscular electroporation: a Phase II non-randomised clinical trial (WIN). NIHR Journals Library; 2016 Apr.

Jaeger E, Webb E, Howarth K, … Wood W et al. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk. Nat Genet. 2008 Jan;40(1):26-8.

Penegar S, Wood W, Lubbe S, Chandler I, Broderick P, Papaemmanuil E, Sellick G, Gray R, Peto J, Houlston R. National study of colorectal cancer genetics. Br J Cancer. 2007 Nov 5;97(9):1305-9.

Glynne-Jones R, Meadows H, Wood W. Chemotherapy or no chemotherapy in clear margins after neoadjuvant chemoradiation in locally advanced rectal cancer: CHRONICLE. A randomised phase III trial of control vs. capecitabine plus oxaliplatin. Clin Oncol (R Coll Radiol) 2007 Jun;19(5):327-9

Bushell M, Wood W, Carpenter G, Pain VM, Morley SJ, Clemens MJ. Disruption of the interaction of mammalian protein synthesis eukaryotic initiation factor 4B with the poly(A)-binding protein by caspase- and viral protease-mediated cleavages. J Biol Chem. 2001 Jun 29;276(26):23922-8.